SAR1A and Schnyder corneal dystrophy: In this study, we hypothesize that selected variants in SAR1a promoter associated with significant increases in HbF levels in African American SCD patients on HU, are also associated with baseline HbF in SCD patients from Cameroon, without any HU treatment.